Table 2.
Pertinent dosimetry characteristics of the eleven patient treatment plans.
| Patient Number | Right/Left | CTV Volume (cc) | PTV Eval Volume (cc) | Mean Heart (cGy) | LAD Max (cGy) | Ipsilateral V20 Dose (%) | Average of total treatment time (min) |
|---|---|---|---|---|---|---|---|
| 1 | R | 32.1 | 124.6 | 13 | 15 | 0 | 34.7 |
| 2 | R | 26.7 | 118.6 | 13 | 17 | 0 | 36.4 |
| 3 | L | 12.3 | 52.5 | 14 | 59 | 0 | 35.8 |
| 4 | R | 10.9 | 64.2 | 13 | 19 | 0 | 38.6 |
| 5 | L | 12.6 | 83 | 25 | 146 | 0 | 37.2 |
| 6 | L | 14.8 | 72.9 | 20 | 85 | 0 | 34.4 |
| 7 | R | 18.1 | 85 | 11 | 18 | 0 | 37.6 |
| 8 | L | 33.9 | 115.3 | 22 | 79 | 0.01 | 38.4 |
| 9 | L | 11.6 | 56.8 | 31 | 67 | 0 | 39.2 |
| 10 | R | 14.8 | 72.7 | 17 | 30 | 0 | 44.3 |
| 11 | L | 2.1 | 22.4 | 11 | 41 | 0 | 37.2 |
(V20: Volume of lung tissue receiving 20 Gy or more, cGy: Centigray, LADMax: Maximum dose to the left anterior descending artery, CTV: Clinical Target Volume, cc: cubic centimeters, PTV Eval: Planning Target Volume Evaluation).